Use of thiazolidinediones and risk of bladder cancer: disease or drugs?

Marloes T Bazelier; Frank de Vries; Peter Vestergaard; Hubert G M Leufkens; Marie L De Bruin

Use of thiazolidinediones and risk of bladder cancer: disease or drugs?

Marloes T Bazelier, Frank de Vries, Peter Vestergaard, Hubert G M Leufkens, Marie L De Bruin

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Pioglitazone, a drug for the treatment of type 2 diabetes mellitus has been associated with bladder cancer in observational studies. Diabetes mellitus itself has also been linked with bladder cancer. The objective was to estimate the risk of bladder cancer for diabetic patients using thialozidinediones (TZDs) compared with patients in other treatment stages of the disease.

Original language	English
Journal	Current Drug Safety
Volume	8
Issue number	5
Pages (from-to)	364-70
Number of pages	7
ISSN	1574-8863
Publication status	Published - Nov 2013

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

@article{943aeb1259c64a04afec76fcb8340550,

title = "Use of thiazolidinediones and risk of bladder cancer: disease or drugs?",

abstract = "Pioglitazone, a drug for the treatment of type 2 diabetes mellitus has been associated with bladder cancer in observational studies. Diabetes mellitus itself has also been linked with bladder cancer. The objective was to estimate the risk of bladder cancer for diabetic patients using thialozidinediones (TZDs) compared with patients in other treatment stages of the disease.",

author = "Bazelier, {Marloes T} and {de Vries}, Frank and Peter Vestergaard and Leufkens, {Hubert G M} and {De Bruin}, {Marie L}",

year = "2013",

month = nov,

language = "English",

volume = "8",

pages = "364--70",

journal = "Current Drug Safety",

issn = "1574-8863",

publisher = "Bentham Science Publishers Ltd.",

number = "5",

}

TY - JOUR

T1 - Use of thiazolidinediones and risk of bladder cancer

T2 - disease or drugs?

AU - Bazelier, Marloes T

AU - de Vries, Frank

AU - Vestergaard, Peter

AU - Leufkens, Hubert G M

AU - De Bruin, Marie L

PY - 2013/11

Y1 - 2013/11

N2 - Pioglitazone, a drug for the treatment of type 2 diabetes mellitus has been associated with bladder cancer in observational studies. Diabetes mellitus itself has also been linked with bladder cancer. The objective was to estimate the risk of bladder cancer for diabetic patients using thialozidinediones (TZDs) compared with patients in other treatment stages of the disease.

AB - Pioglitazone, a drug for the treatment of type 2 diabetes mellitus has been associated with bladder cancer in observational studies. Diabetes mellitus itself has also been linked with bladder cancer. The objective was to estimate the risk of bladder cancer for diabetic patients using thialozidinediones (TZDs) compared with patients in other treatment stages of the disease.

M3 - Journal article

C2 - 24215315

SN - 1574-8863

VL - 8

SP - 364

EP - 370

JO - Current Drug Safety

JF - Current Drug Safety

IS - 5

ER -

Use of thiazolidinediones and risk of bladder cancer: disease or drugs?

Abstract

AUB Link

Fingerprint

Cite this